Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 1 | +905K | 94% | $4.42 | +$4M |
Sells | 2 | -58K | 6% | $4.94 | -$287K |
Net | -1 | +847K | 88% | +$3.71M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Nancy A. Simonian | Director | $1.07M | Jun 5, 2024 | ||
Jason Haas | Chief Financial Officer | $262K | Mar 31, 2024 | ||
Kristin Stephens | Chief Development Officer | $245K | Mar 31, 2024 | ||
Gerald E. Quirk | Chief Legal & Compliance Offic | $222K | Mar 27, 2024 | ||
Conley Chee | President & CEO, Director | $218K | Mar 31, 2024 | ||
Timothy Tyson | Director | $164K | Jun 5, 2024 | ||
David Roth | Chief Medical Officer | $137K | -$108K | -44.3% | Apr 3, 2024 |
Marsha Fanucci | Director | $79.2K | Jun 5, 2024 | ||
Wirth Peter | Director | $79.2K | Jun 5, 2024 | ||
Deborah Dunsire | Director | $79.2K | Jun 5, 2024 | ||
Sue Gail Eckhardt | Director | $79.2K | Jun 5, 2024 | ||
Andrew M. Oh | Director | $79.2K | Jun 5, 2024 | ||
Richard A. Young | Director | $52.8K | -$178K | -77.2% | Jun 28, 2024 |
Srinivas Akkaraju | Director | $52.8K | +$4M | Jun 5, 2024 | |
Eric R. Olson | Chief Scientific Officer | $29.4K | Jul 17, 2023 | ||
Mark J. Alles | Director | $28K | Sep 16, 2023 | ||
Amir Nashat | Director | Jun 1, 2022 | |||
Phillip A. Sharp | Director | Jun 1, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|